In addition, upregulation of Flot-2 activates PI3K/Akt3 and inhibits Foxo1 activity, leading to an acceleration of the cell cycle through downstream effectors of Foxo1 and subsequently to proliferation of NPC cells. The gene discussed is AKT3; the disease is nasopharyngeal carcinoma.